Alexa B. R. McIntyre

Alexa B. R. McIntyre

Auto-generated profile, based on publicly available information

Alexa B. R. McIntyre

Weill Cornell Medical College

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2016 in Scientific Data
Verified
Journal Article
Open access
PDF file
JZJustin M. Zook
Justin M. Zook
DCDavid Catoe
David Catoe
JMJennifer McDaniel
Jennifer McDaniel
LVLindsay Vang
Lindsay Vang
NSNoah Spies
Noah Spies
MSMarc Salit
Marc Salit
The Genome in a Bottle Consortium, hosted by the National Institute of Standards and Technology (NIST) is creating reference materials and data for human genome sequencing, as well as methods for genome comparison and benchmarking. Here, we describe a large, diverse set of sequencing data for seven human genomes; five are current or candidate NIST Reference Materials. The pilot genome, NA12878, has been released as NIST RM 8398. We also describe data from two Personal Genome Project trios, one of Ashkenazim Jewish ancestry and one of Chinese ancestry. The data come from 12 technologies: BioNano Genomics, Complete Genomics paired-end and LFR, Ion Proton exome, Oxford Nanopore, Pacific Biosciences, SOLiD, 10X Genomics GemCode WGS, and Illumina exome and WGS paired-end, mate-pair, and synthetic long reads. Cell lines, DNA, and data from these individuals are publicly available. Therefore, we expect these data to be useful for revealing novel information about the human genome and improving sequencing technologies, SNP, indel, and structural variant calling, and de novo assembly.

1 November 2016 in Cell Host & Microbe
Verified
Journal Article
Open access
NGNandan S. Gokhale
Nandan S. Gokhale
AMAlexa B.R. McIntyre
Alexa B.R. McIntyre
MMMichael McFadden
Michael McFadden
ARAllison E. Roder
Allison E. Roder
EKEdward M. Kennedy
Edward M. Kennedy
SHStacy Horner
Stacy Horner
The RNA modification N6-methyladenosine (m6A) post-transcriptionally regulates RNA function. The cellular machinery that controls m6A includes methyltransferases and demethylases that add or remove this modification, as well as m6A-binding YTHDF proteins that promote the translation or degradation of m6A-modified mRNA. We demonstrate that m6A modulates infection by hepatitis C virus (HCV). Depletion of m6A methyltransferases or an m6A demethylase, respectively, increases or decreases infectious HCV particle production. During HCV infection, YTHDF proteins relocalize to lipid droplets, sites of viral assembly, and their depletion increases infectious viral particles. We further mapped m6A sites across the HCV genome and determined that inactivating m6A in one viral genomic region increases viral titer without affecting RNA replication. Additional mapping of m6A on the RNA genomes of other Flaviviridae, including dengue, Zika, yellow fever, and West Nile virus, identifies conserved regions modified by m6A. Altogether, this work identifies m6A as a conserved regulatory mark across Flaviviridae genomes.

21 December 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SCSarah L. Castro-Wallace
Sarah L. Castro-Wallace
CCCharles Y. Chiu
Charles Y. Chiu
KJKristen K. John
Kristen K. John
SSSarah E. Stahl
Sarah E. Stahl
KRKathleen H. Rubins
Kathleen H. Rubins
Aaron BurtonAaron Burton
Aaron Burton
We evaluated the performance of the MinION DNA sequencer in-flight on the International Space Station (ISS), and benchmarked its performance off-Earth against the MinION, Illumina MiSeq, and PacBio RS II sequencing platforms in terrestrial laboratories. Samples contained equimolar mixtures of genomic DNA from lambda bacteriophage, Escherichia coli (strain K12, MG1655) and Mus musculus (female BALB/c mouse). Nine sequencing runs were performed aboard the ISS over a 6-month period, yielding a total of 276,882 reads with no apparent decrease in performance over time. From sequence data collected aboard the ISS, we constructed directed assemblies of the ~4.6 Mb E. coli genome, ~48.5 kb lambda genome, and a representative M. musculus sequence (the ~16.3 kb mitochondrial genome), at 100%, 100%, and 96.7% consensus pairwise identity, respectively; de novo assembly of the E. coli genome from raw reads yielded a single contig comprising 99.9% of the genome at 98.6% consensus pairwise identity. Simulated real-time analyses of in-flight sequence data using an automated bioinformatic pipeline and laptop-based genomic assembly demonstrated the feasibility of sequencing analysis and microbial identification aboard the ISS. These findings illustrate the potential for sequencing applications including disease diagnosis, environmental monitoring, and elucidating the molecular basis for how organisms respond to spaceflight.

21 September 2017 in Genome Biology
Verified
Journal Article
Open access
PDF file
AMAlexa B. R. McIntyre
Alexa B. R. McIntyre
RORachid Ounit
Rachid Ounit
EAEbrahim Afshinnekoo
Ebrahim Afshinnekoo
RPRobert J. Prill
Robert J. Prill
EHElizabeth Hénaff
Elizabeth Hénaff
Christopher MasonChristopher Mason
Christopher Mason
One of the main challenges in metagenomics is the identification of microorganisms in clinical and environmental samples. While an extensive and heterogeneous set of computational tools is available to classify microorganisms using whole-genome shotgun sequencing data, comprehensive comparisons of these methods are limited. In this study, we use the largest-to-date set of laboratory-generated and simulated controls across 846 species to evaluate the performance of 11 metagenomic classifiers. Tools were characterized on the basis of their ability to identify taxa at the genus, species, and strain levels, quantify relative abundances of taxa, and classify individual reads to the species level. Strikingly, the number of species identified by the 11 tools can differ by over three orders of magnitude on the same datasets. Various strategies can ameliorate taxonomic misclassification, including abundance filtering, ensemble approaches, and tool intersection. Nevertheless, these strategies were often insufficient to completely eliminate false positives from environmental samples, which are especially important where they concern medically relevant species. Overall, pairing tools with different classification strategies (k-mer, alignment, marker) can combine their respective advantages. This study provides positive and negative controls, titrated standards, and a guide for selecting tools for metagenomic analyses by comparing ranges of precision, accuracy, and recall. We show that proper experimental design and analysis parameters can reduce false positives, provide greater resolution of species in complex metagenomic samples, and improve the interpretation of results.

20 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAlexa B. R. McIntyre
Alexa B. R. McIntyre
NGNandan S. Gokhale
Nandan S. Gokhale
LCLeandro Cerchietti
Leandro Cerchietti
SJSamie R. Jaffrey
Samie R. Jaffrey
SHStacy Horner
Stacy Horner
Christopher MasonChristopher Mason
Christopher Mason
Many cellular mRNAs contain the modified base m6A, and recent studies have suggested that various stimuli can lead to changes in m6A. The most common method to map m6A and to predict changes in m6A between conditions is methylated RNA immunoprecipitation sequencing (MeRIP-seq), through which methylated regions are detected as peaks in transcript coverage from immunoprecipitated RNA relative to input RNA. Here, we generated replicate controls and reanalyzed published MeRIP-seq data to estimate reproducibility across experiments. We found that m6A peak overlap in mRNAs varies from ~30 to 60% between studies, even in the same cell type. We then assessed statistical methods to detect changes in m6A peaks as distinct from changes in gene expression. However, from these published data sets, we detected few changes under most conditions and were unable to detect consistent changes across studies of similar stimuli. Overall, our work identifies limits to MeRIP-seq reproducibility in the detection both of peaks and of peak changes and proposes improved approaches for analysis of peak changes.

13 August 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
HIHasan Imam
Hasan Imam
MKMohsin Khan
Mohsin Khan
NGNandan S. Gokhale
Nandan S. Gokhale
AMAlexa B. R. McIntyre
Alexa B. R. McIntyre
GKGeon-Woo Kim
Geon-Woo Kim
ASAleem Siddiqui
Aleem Siddiqui
Significance: N6 -methyladenosine (m 6 A) has recently been found to regulate numerous aspects of RNA biology. Similar to methylation of cytosine residues in DNA, eukaryotic RNA is modified by enzymatic addition of methyl groups at adenosines. m 6 A modification of RNA affects a wide variety of RNA functions, including mRNA stability, translation, and in the case of viruses, viral replication and production. Our investigation revealed that the adenosine residues present in the known m 6 A consensus motif within the 5′ epsilon stem loop of pregenomic RNA and the 3′ ends of all the hepatitis B virus (HBV) transcripts are m 6 A modified. We demonstrate here that m 6 A modification differentially modulates HBV RNA stability and reverse transcription, thereby playing two distinct regulatory roles in the HBV life cycle.